2015
DOI: 10.4321/s1135-57272015000600008
|View full text |Cite
|
Sign up to set email alerts
|

Riesgo cardiovascular asociado al consumo de antiinflamatorios no esteroideos: estudio de cohortes retrospectivo en un área de salud, 2008-2012

Abstract: RESUMENFundamentos: Desde el ensayo clínico VIGOR cuyos resultados asociaron el uso del medicamento rofecoxib a la ocurrencia de eventos cardiovasculares se ha observado un aumento en patologías cardiovasculares asociadas al uso de antiinflamatorios no esteroideos. El objetivo de esta investigación fue evaluar el impacto cardiovascular asociado al consumo de antiinflamatorios en un Área de Salud de Castilla La-Mancha (España).Métodos: Estudio retrospectivo de cohortes de base poblacional en un área de salud de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 20 publications
0
1
0
1
Order By: Relevance
“…Propionic acid derivatives, such as ibuprofen, which are the most consumed anti-inflammatory drugs in Spain, are the only ones that increased cardiovascular risk with time of use. (11) European Society of Cardiology -Karolinska Institute (Stockholm -Sweden) In a national population-based cohort of 7 million people, from July 2005 to December 2008, they performed an analysis for different cardiovascular outcomes in the entire population after excluding individuals with a prior diagnosis of cardiovascular disease (size of sample, n = 6,991,645). Proportional hazard ratios (HRs) revealed no significant association of coxib use with the risk of myocardial infarction, ischemic stroke, or heart failure.…”
Section: Spanish Journal Of Public Healthmentioning
confidence: 99%
“…Propionic acid derivatives, such as ibuprofen, which are the most consumed anti-inflammatory drugs in Spain, are the only ones that increased cardiovascular risk with time of use. (11) European Society of Cardiology -Karolinska Institute (Stockholm -Sweden) In a national population-based cohort of 7 million people, from July 2005 to December 2008, they performed an analysis for different cardiovascular outcomes in the entire population after excluding individuals with a prior diagnosis of cardiovascular disease (size of sample, n = 6,991,645). Proportional hazard ratios (HRs) revealed no significant association of coxib use with the risk of myocardial infarction, ischemic stroke, or heart failure.…”
Section: Spanish Journal Of Public Healthmentioning
confidence: 99%
“…Por otro lado, Sánchez Serrano y cols. encontraron, en un estudio de cohortes realizado sobre población española, que el ibuprofeno y otros derivados del ácido propiónico incrementan el riesgo cardiovascular con el tiempo: riesgo relativo (IC 95 %) 2,6 (2,2-3,1), incremento al mes de consumo 1,0 (1,0-1,0), p < 0,001(13).En otro estudio de cohortes, Abajo y cols. encontraron un aumento significativo del riesgo de sufrir un infarto agudo de miocardio no fatal, asociado con el uso a largo plazo (> 1 año) de AINE (OR = 1,4; 1,1-1,8) (14).Junto con los AINE, otros fármacos son utilizados en el manejo del dolor crónico.…”
unclassified